Caroline Palomeque's Stock Ratings

Maxim Group Analyst

Caroline Palomeque is an analyst at Maxim Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/14/2025

Overall Average Return

16.2%

Smart Score

60%

Overall Average Return Percentile

75th

Number of Ratings

12
Buy NowGet Alert
08/14/2024DAREBuy Now
Dare Bioscience
$2.93—
Caroline Palomeque59%
—DowngradeBuy → HoldGet Alert
09/07/2023HRMYBuy Now
Harmony Biosciences
$34.3771.66%
Caroline Palomeque59%
 → $59Initiates → BuyGet Alert
09/07/2023KRYSBuy Now
Krystal Biotech
$134.5314.47%
Caroline Palomeque59%
 → $154Initiates → BuyGet Alert
03/27/2023HALOBuy Now
Halozyme Therapeutics
$50.4714.92%
Caroline Palomeque59%
 → $58Reinstates → BuyGet Alert
03/16/2023CEREBuy Now
Cerevel Therapeutics Hldg
——
Caroline Palomeque59%
 → $22Reinstates → HoldGet Alert
08/30/2022ASNDBuy Now
Ascendis Pharma
$160.923.16%
Caroline Palomeque59%
 → $166Assumes → BuyGet Alert
06/23/2022DNLIBuy Now
Denali Therapeutics
$14.00178.57%
Caroline Palomeque59%
 → $39Initiates → BuyGet Alert
06/23/2022RGNXBuy Now
Regenxbio
$8.22642.15%
Caroline Palomeque59%
 → $61Initiates → BuyGet Alert
06/23/2022AVXLBuy Now
Anavex Life Sciences
$8.10393.82%
Caroline Palomeque59%
 → $40Initiates → BuyGet Alert
04/08/2022AGRXBuy Now
Agile Therapeutics
$1.51—
Caroline Palomeque59%
—DowngradeBuy → HoldGet Alert
11/29/2018AGRXBuy Now
Agile Therapeutics
$1.5198.68%
Caroline Palomeque59%
 → $3Initiates → BuyGet Alert
08/17/2018DAREBuy Now
Dare Bioscience
$2.932.41%
Caroline Palomeque59%
 → $3Initiates → BuyGet Alert

Recent Analyst Stock Rating News

The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved